NCT05481957View on ClinicalTrials.gov

Vortioxetine Adjunctive Treatment in Bipolar Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

June 28, 2023

Study Completion Date

August 15, 2023

Conditions
Bipolar Depression
Interventions
DRUG

Vortioxetine

5-10mg for 16 weeks

DRUG

valprote

500\~1000mg for 16 weeks

Trial Locations (1)

310000

Department of Psychiatry, First Affiliated Hospital of Zhejiang University, Hangzhou

All Listed Sponsors
collaborator

Zhejiang University

OTHER

lead

First Affiliated Hospital of Zhejiang University

OTHER